LBEL EFFET PARFAIT

Product NDC
13537-434
11-digit product format
135370434
Labeler code
13537
Product ID
13537-434_928b87c9-da1d-4633-a52f-b0d29642eeef
Type
HUMAN OTC DRUG
Nonproprietary name
Octinoxate and Titanium Dioxide
Dosage form
LOTION
Route
TOPICAL
Labeler
Ventura Corporation LTD.
Application
part352
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2012-09-14
Marketing end
0000-00-00
Substance
OCTINOXATE; TITANIUM DIOXIDE
Active strength
0 g/mL; g/mL
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct13537-434DDiscontinued by firm2026-10-23
excluded packagepackage13537-43413537-434-02DDiscontinued by firm2026-10-23
excluded packagepackage13537-43413537-434-04DDiscontinued by firm2026-10-23
excluded packagepackage13537-43413537-434-06DDiscontinued by firm2026-10-23

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 88 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage13537-434-06DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage13537-434-02DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage13537-434-04DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage13537-434-06DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage13537-434-02DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage13537-434-04DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductIInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage13537-434-06IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage13537-434-04IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage13537-434-02IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductIInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage13537-434-06IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage13537-434-04IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage13537-434-02IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductIInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage13537-434-06IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage13537-434-04IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage13537-434-02IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductIInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage13537-434-06IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage13537-434-04IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage13537-434-02IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductIInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage13537-434-06IInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage13537-434-04IInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage13537-434-02IInactivated by FDA302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductIInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage13537-434-06IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage13537-434-04IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage13537-434-02IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductIInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage13537-434-06IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage13537-434-04IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage13537-434-02IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductIInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage13537-434-06IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage13537-434-04IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage13537-434-02IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductIInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage13537-434-06IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage13537-434-04IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage13537-434-02IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductIInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage13537-434-06IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage13537-434-04IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage13537-434-02IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproductIInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage13537-434-06IInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage13537-434-04IInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage13537-434-02IInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproductIInactivated by FDA834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage13537-434-06IInactivated by FDA834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage13537-434-04IInactivated by FDA834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage13537-434-02IInactivated by FDA834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproductIInactivated by FDA1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage13537-434-06IInactivated by FDA1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage13537-434-04IInactivated by FDA1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage13537-434-02IInactivated by FDA1332a3947898…d4bfe170f9cd…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
OctinoxateACTIVE INGREDIENT4Y5P7MUD51LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Titanium DioxideACTIVE INGREDIENT15FIX9V2JPLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
OctinoxateACTIVE MOIETY4Y5P7MUD51LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
Titanium DioxideACTIVE MOIETY15FIX9V2JPLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
.ALPHA.-TOCOPHEROL ACETATEINACTIVE INGREDIENT9E8X80D2L0LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
ARABICA COFFEE BEANINACTIVE INGREDIENT3SW678MX72LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBHLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171KLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RALBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
BUTYLPARABENINACTIVE INGREDIENT3QPI1U3FV8LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
CANDELILLA WAXINACTIVE INGREDIENTWL0328HX19LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
CARNAUBA WAXINACTIVE INGREDIENTR12CBM0EIZLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
CETEARYL GLUCOSIDEINACTIVE INGREDIENT09FUA47KNALBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
CETOSTEARYL ALCOHOLINACTIVE INGREDIENT2DMT128M1SLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
CHOLESTEROLINACTIVE INGREDIENT97C5T2UQ7JLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
CYCLOMETHICONE 5INACTIVE INGREDIENT0THT5PCI0RLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
CYCLOMETHICONE 6INACTIVE INGREDIENTXHK3U310BALBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
DIAZOLIDINYL UREAINACTIVE INGREDIENTH5RIZ3MPW4LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1OLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
ETHYLPARABENINACTIVE INGREDIENT14255EXE39LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
HEXYL LAURATEINACTIVE INGREDIENT4CG9F9W01QLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
ISOBUTYLPARABENINACTIVE INGREDIENT0QQJ25X58GLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
MICROCRYSTALLINE WAXINACTIVE INGREDIENTXOF597Q3KYLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
OCTYLDODECANOLINACTIVE INGREDIENT461N1O614YLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
PALMITOYL OLIGOPEPTIDEINACTIVE INGREDIENTHO4ZT5S86CLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
PALMITOYL TETRAPEPTIDE-7INACTIVE INGREDIENTQ41S464P1RLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
PEG/PPG-18/18 DIMETHICONEINACTIVE INGREDIENT9H0AO7T794LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
PEG/PPG-19/19 DIMETHICONEINACTIVE INGREDIENTEHH90CO7TLLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
PETROLATUMINACTIVE INGREDIENT4T6H12BN9ULBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3TLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
POLYGLYCERYL-2 DIPOLYHYDROXYSTEARATEINACTIVE INGREDIENT9229XJ4V12LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
POLYGLYCERYL-4 ISOSTEARATEINACTIVE INGREDIENT820DPX33S7LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
POLYSORBATE 20INACTIVE INGREDIENT7T1F30V5YHLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
POTASSIUM SORBATEINACTIVE INGREDIENT1VPU26JZZ4LBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8XLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
TRIETHOXYCAPRYLYLSILANEINACTIVE INGREDIENTLDC331P08ELBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
WATERINACTIVE INGREDIENT059QF0KO0RLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1
YELLOW WAXINACTIVE INGREDIENT2ZA36H0S2VLBEL EFFET PARFAIT SIGNS OF AGE APPEARANCE MINIMIZER FOUNDATION SPF 20 (OCTINOXATE AND TITANIUM DIOXIDE) LOTION [VENTURA CORPORATION LTD.]1